A strain of the common cold virus has been found to potentially target, infect and destroy cancer cells in patients with bladder cancer, a new study in the medical journal Clinical Cancer Research reports. No trace of the cancer was found in one patient following treatment with the virus.
Researchers from the University of Surrey and Royal Surrey County Hospital investigated the safety and tolerability of exposure to the oncolytic (‘cancer-killing’) virus coxsackievirus (CVA21), a naturally occurring strain of the common cold, in fifteen patients with non-muscle invasive bladder cancer (NMIBC). NMIBC is found in the tissue of the inner surface of the bladder and is the tenth most common cancer in the UK with approximately 10,000 people each year diagnosed with the illness.
Current treatments for this cancer are problematic. Transurethral resection, an invasive procedure that removes all visible lesions, has a high tumour recurrence rate ranging from 50 per cent to 70 per cent as well as a high tumour progression rate between 10 per cent and 20 per cent over a period of two to five years. Another common course of treatment, immunotherapy with Bacille Calmette-Guerin, a live bacterium used to treat bladder cancer, has been found to have serious side effects in one third of NMIBC patients while one third do not respond to the treatment at all.
During this pioneering study fifteen NMIBC patients, one week prior to pre scheduled surgery to remove their tumours, received CVA21 via a catheter in the bladder. Examination of tissue samples post-surgery discovered that the virus was highly selective, targeting only cancerous cells in the organ and leaving all other cells intact. The virus was found to have infected cancerous cells and replicated itself causing the cells to rupture and die. Urine samples taken from patients on alternate days detected ‘shedding’ from the virus indicating that once virally infected cancer cells had died, the newly replicated virus continued to attack more cancerous cells in the organ.
Typically tumours in the bladder do not have immune cells, preventing a patient’s own immune system from eliminating the cancer as it grows. Evidence suggests treatment with CVA21 inflames the tumour causing immune cells to rush into the cancer environment, targeting and killing the cancer cells. These tumours devoid of immune cells are known as ‘cold’ areas immunologically; however, treatment with the virus causes inflammation and immune cell stimulation to create ‘immunological ‘heat’. ‘Hot’ tumours in this way are more likely to be rejected by the immune system.
Following treatment with the virus cell death was identified in the majority of the patients’ tumours. In one patient no trace of the cancer was found during surgery.
Hardev Pandha, Principal Investigator of the study and Professor of Medical Oncology at the University of Surrey, said: “Non-muscle invasive bladder cancer is a highly prevalent illness that requires an intrusive and often lengthy treatment plan. Current treatment is ineffective and toxic in a proportion of patients and there is an urgent need for new therapies.
“Coxsackievirus could help revolutionise treatment for this type of cancer. Reduction of tumour burden and increased cancer cell death was observed in all patients and removed all trace of the disease in one patient following just one week of treatment, showing its potential effectiveness. Notably, no significant side effects were observed in any patient.”
Dr Nicola Annels, Research Fellow at the University of Surrey, said: “Traditionally viruses have been associated with illness however in the right situation they can improve our overall health and wellbeing by destroying cancerous cells. Oncolytic viruses such as the coxsackievirus could transform the way we treat cancer and could signal a move away from more established treatments such as chemotherapy.”
The Latest on: Bladder cancer
via Google News
The Latest on: Bladder cancer
- Strain of common cold virus could revolutionize treatment of bladder canceron July 8, 2019 at 6:21 am
A strain of the common cold virus has been found to potentially target, infect and destroy cancer cells in patients with bladder cancer, a new study reports. No trace of the cancer was found in one ... […]
- Common cold virus strain could be a breakthrough in bladder cancer treatmenton July 7, 2019 at 11:14 pm
Scientists in the UK have found a new way to treat bladder cancer, using a strain of one of the viruses that cause the common cold. The virus is called Coxsackie virus CVA21, and it was found to be ... […]
- Common Cold Virus Could Destroy Bladder Cancer, Study Suggestson July 7, 2019 at 9:25 pm
Common colds are so-called because of how common they are. Usually, these mild conditions are caused by a virus, can be easily cured with over-the-counter medication, proper rest and maybe some ... […]
- Common cold virus targets, and kills, bladder cancer in exciting early human trialon July 7, 2019 at 7:06 pm
was seen to selectively attack and kill bladder cancer cells(Credit: katerynakon/Depositphotos) An early-stage study has found a strain of the common cold virus can effectively target and destroy ... […]
- The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 proteinon July 7, 2019 at 12:00 am
All prices are NET prices. VAT will be added later in the checkout. Rent or Buy article Get time limited or full article access on ReadCube. ... […]
- Common Cold Virus can Potentially Treat Bladder Canceron July 6, 2019 at 12:41 am
A strain of common cold-causing virus namely Coxsackievirus (CVA21) has been found to target and selectively kill bladder cancer cells in patients with non-muscle invasive bladder cancer (NMIBC) ... […]
- 'Revolutionary' study uses common cold virus to attack bladder canceron July 5, 2019 at 1:20 pm
New research published Friday in Clinical Cancer Research journal has found that a strain of the common cold — yes, the one that gives you the sniffles about twice a year — was highly capable of ... […]
- Strain of Common Cold Virus Could Cure Bladder Canceron July 5, 2019 at 10:59 am
Patients with bladder cancer were given a dose of a strain of the common cold virus one week before they were set to have surgery to remove cancerous tumors. (ljuba photo/Getty Images) A strain of the ... […]
- Common cold virus can kill bladder cancer cellson July 5, 2019 at 8:25 am
A strain of the common cold virus could be used to cure bladder cancer, a small study suggests. Scientists found the particular strain called coxsackievirus (CVA21) destroys cancerous tumours on the ... […]
- Common Cold Virus Can Attack And Kill Bladder Cancer Cells: Studyon July 5, 2019 at 5:28 am
A type of virus called coxsackievirus (CVA21) that is known to cause common cold has the ability to attack and kill all the cancer cells in the bladder, according to a recent small study. The research ... […]
via Bing News